Benjamin Cohen - Y-Brush | LinkedIn (original) (raw)
About
I thrive on building bold, innovative and result-oriented companies.
Growing…
Articles by Benjamin
Activity
Experience & Education
Y-Brush
View Benjamin’s full experience
See their title, tenure and more.
Publications
J Clin Virol. 2013 Sep;58(1):114-9. doi: 10.1016/j.jcv.2013.05.025. Epub 2013 Jul 3. Sep 2013
BACKGROUND:
The emergence of novel A(H1N1)pdm2009 virus threatened to lead to frequent severe manifestations.
OBJECTIVES:
To describe the clinical, virological, and biological characteristics of the disease and identify the factors associated with severe presentations.
STUDY DESIGN:
This prospective multicenter study recruited consecutive hospitalized patients with confirmed A(H1N1)pdm2009 disease. Clinical, virological and biological assessments were carried out at inclusion and…
BACKGROUND:
The emergence of novel A(H1N1)pdm2009 virus threatened to lead to frequent severe manifestations.
OBJECTIVES:
To describe the clinical, virological, and biological characteristics of the disease and identify the factors associated with severe presentations.
STUDY DESIGN:
This prospective multicenter study recruited consecutive hospitalized patients with confirmed A(H1N1)pdm2009 disease. Clinical, virological and biological assessments were carried out at inclusion and 30 days post-inclusion. Disease manifestations were assessed by an adjudication committee using pre-identified definitions of complications and severity scores.
RESULTS:
The study analyzed from November 30th, 2009 to February 8th, 2010, 40 hospitalized patients, 21 children and 19 adults. Eighteen (45%) were considered to have severe presentations. Except age, main characteristics in children and adults did not differ. The majority (18/21) of children and all adults had a respiratory presentation; extra-respiratory manifestations tended to be more frequent in children (12 vs. 6, P=0.10). Two children against 5 adults presented acute respiratory distress syndrome (ARDS, P=0.23), but more children suffered respiratory failure (7 vs. 1, P=0.046) without ARDS. At day 30, one death had occurred in each group. The main factor associated with non-severe presentation was an early (<48 h) implementation of oseltamivir treatment (P=0.038).
CONCLUSIONS:
Although the study failed to achieve its main objective, due mainly to the difficulty of carrying a study of this nature in the midst of a pandemic, it allowed the description of a panel of unusual and complicated forms and confirmed the added value of early oseltamivir treatment in limiting severity in hospitalized children and adults.
Other authors
Projects
Startup Weekend Sciences
Jun 2016
Co-organizer for the Startup Weekend Lyon Sciences 2016 event
Hacking Health Lyon
Jan 2016
Member of the steering group.
Apr 2015
Gareremix is a project organized by GrandLyon, Rhône Alpes region, & SNCF - Gares and connnections to innovate and invent new services in the train station.
3 days of collaborative innovation, design of service and construction of a real functional prototype, inside the Lyon St Paul train station.
Part of the "Lampistes" team, we built a funny interactive compost and recycle bin, fostering the touristic development of the area served by the station, and creating social link in the…
Gareremix is a project organized by GrandLyon, Rhône Alpes region, & SNCF - Gares and connnections to innovate and invent new services in the train station.
3 days of collaborative innovation, design of service and construction of a real functional prototype, inside the Lyon St Paul train station.
Part of the "Lampistes" team, we built a funny interactive compost and recycle bin, fostering the touristic development of the area served by the station, and creating social link in the district.
Other creators
-
See project Startup Weekend Medtech
Jan 2016 - Jun 2016
Lead organizer for the first French Startup Weekend for Medtechs.
The event will be held at the ECAM School in Lyon on June 3-4-5th 2016.
Feel free to contact me if you want to be a sponsor, mentor or judge for this Startup weekend.
Other creators
Honors & Awards
Innova laureat
-
Apr 2018
Start-Ulm Laureat
-
Nov 2017
SOFMER Innovation laureat
-
Oct 2017
Lyon Startup Laureate
lyon start-up
Dec 2016
French Tech Grant
French Tech
Jul 2016
Industrie du futur laureat
-
Languages
Anglais
Full professional proficiency
Français
Native or bilingual proficiency
Organizations
ExponentialMed
Co-founder
Jun 2015 - Jun 2017
ExponentialMed's aim is to federate the MedTech community. We want Doctors to meet investors and entrepreneurs such as new devices & services can emerge quickly.
BeyondLab
Ambassador
Jan 2015 - Jan 2017
BeyondLab (non-profit organization) connects researchers and entrepreneurs in MedTech, BioTech, CleanTech and IT.
O.S.E.
Founder
May 2008 - Jan 2015
OSE is a French organization offering marketing compaigns with "flash-mobs" to companies, using mainly social networks. OSE was a non profit organization, and a fascinating work for me and my team. Our ambitious work led OSE to the first rank in France for this kind of marketing.
Recommendations received
More activity by Benjamin
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Others named Benjamin Cohen in United States
546 others named Benjamin Cohen in United States are on LinkedIn
See others named Benjamin Cohen